Total Plasma Homocysteine and Related Amino Acids in End-Stage Renal Disease (ESRD) Patients Measured by Gas Chromatography-Mass Spectrometry – Comparison with the Abbott IMx Homocysteine Assay and the HPLC Method
- 31 January 2001
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 39 (8), 681-690
- https://doi.org/10.1515/cclm.2001.112
Abstract
Increased concentrations of homocysteine probably contribute to the high cardiovascular morbidity and mortality in hemodialysed end-stage renal disease (ESRD) patients and are determined by a variety of factors such as age, residual renal function, and vitamin status. Fasting plasma concentrations of total homocysteine, methionine, cysteine, and cystathionine were determined by gas chromatography-mass spectrometry (GC-MS) in 131 ESRD patients receiving daily oral folate (160–320 μg) and vitamin B6 (10–20 mg) supplements. Concentrations of homocysteine determined by GC-MS were compared with those measured by high-performance liquid chromatography (HPLC) and an immunofluorescence method (IMx analyzer) using Passing-Bablok regression analysis. Mean plasma concentration of total homocysteine determined by GC-MS (28.7±11.9 μmol/l [mean±SD]) was significantly lower than that determined by HPLC (34.0±14.5 μmol/l; p<0.001) or IMx (32.4±13.9 μmol/l; p<0.001). A close correlation existed between GC-MS and HPLC (r=0.931; y=1.203 x+0.279) and GC-MS and IMx (r=0.896; y=1.105 x+0.766). Linear regression analysis showed positive correlations between plasma concentrations of homocysteine and cysteine (r=0.434; p<0.001) and homocysteine and cystathionine (r=0.187; p=0.032). Plasma concentrations of homocysteine correlated negatively with folate (r=−0.281; p=0.001) and vitamin B12 (r=−0.229; p=0.009). GC-MS proved to be a sensitive and reliable method for the determination of total plasma homocysteine and related amino acids. Despite vitamin supplementation, ESRD patients requiring chronic maintenance hemodialysis, have high plasma concentrations of homocyst(e)ine which seems to be metabolized mainly within the transsulfuration pathway, while remethylation to methionine seems to be disturbed.Keywords
This publication has 34 references indexed in Scilit:
- Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European menThe Lancet, 2000
- Serum total homocysteine and coronary heart disease: prospective study in middle aged menHeart, 1999
- Homocysteine and ArteriosclerosisCirculation, 1999
- Recent data are not in conflict with homocysteine as a cardiovascular risk factorCurrent Opinion in Lipidology, 1998
- Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B VitaminsCell Metabolism, 1998
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectPublished by American Medical Association (AMA) ,1997
- Clinical chemistry and molecular biology of homocysteine metabolism: An updateClinical Biochemistry, 1997
- Plasma homocysteine and cardiovascular disease mortalityThe Lancet, 1997
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995